Takarazuka, Japan

Yukio Asami


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 57(Granted Patents)


Location History:

  • Hyogo, JP (1985)
  • Takarazuka, JP (1985)
  • Kitamoto, JP (1986)

Company Filing History:


Years Active: 1985-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yukio Asami

Introduction

Yukio Asami is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 3 patents to his name, Asami's work focuses on creating innovative solutions for medical applications.

Latest Patents

Asami's latest patents include the development of N-(substituted piperazinyl) alkylbicyclic succinimide derivatives. These compounds are designed to serve as anti-anxiety and anti-allergic drugs. The specific formula involves various alkylene groups and phenyl substitutions, showcasing a complex structure that enhances their therapeutic potential. Another significant patent involves substituted succinimides, which are also aimed at providing antianxious effects. These derivatives are characterized by their unique chemical structures, making them valuable in pharmaceutical formulations.

Career Highlights

Yukio Asami is currently associated with Sumitomo Chemical Company, Limited, where he continues to innovate in the field of chemical research. His work has not only contributed to the company's portfolio but has also advanced the understanding of succinimide derivatives in medicinal chemistry.

Collaborations

Asami has collaborated with notable colleagues such as Kikuo Ishizumi and Fujio Antoku. Their combined expertise has fostered a productive environment for research and development, leading to significant advancements in their respective fields.

Conclusion

Yukio Asami's contributions to the field of chemistry, particularly through his innovative patents, highlight his role as a key inventor in pharmaceutical research. His work continues to impact the development of important medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…